NUS - Nu Skin Enterprises - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US67018T1051
Skin Care, Cosmetics, Nutritional Supplements, Wellness Products
Nu Skin Enterprises, Inc. is a global company that specializes in creating and distributing a wide range of beauty and wellness products. Its product portfolio includes skin care devices, cosmetics, and personal care items, such as the popular ageLOC LumiSpa and ageLOC LumiSpa iO, as well as nutricentials skin care products that cater to diverse skin types and needs.
In addition to its beauty products, Nu Skin also offers a variety of wellness solutions, including LifePak nutritional supplements, the ageLOC TR90 weight management system, and Beauty Focus Collagen+, which are designed to promote overall health and well-being. The company is committed to ongoing research and development, continually innovating and improving its products to meet the evolving needs of its customers.
Nu Skin's products are sold under three distinct brands: Nu Skin, Pharmanex, and ageLOC. The company has established a diverse distribution network, which includes retail stores, its website, digital platforms, and a network of independent direct sellers and marketers. This allows customers to purchase products conveniently and easily, with the option to receive personalized support and guidance from trained sales representatives.
Founded in 1984, Nu Skin Enterprises, Inc. is headquartered in Provo, Utah, and has grown into a global enterprise with a strong online presence, including its website at https://www.nuskin.com. Through its commitment to innovation, quality, and customer satisfaction, Nu Skin has established itself as a leader in the beauty and wellness industry.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
NUS Stock Overview
| Market Cap in USD | 545m |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| GiC SubIndustry | Personal Care Products |
| TER | 0.00% |
| IPO / Inception | 1996-11-21 |
NUS Stock Ratings
| Growth 5y | -65.5 |
| Fundamental | 8.30 |
| Dividend | 60.7 |
| Rel. Performance vs Sector | -6.47 |
| Analysts | 3.00/5 |
| Fair Price Momentum | 9.10 USD |
| Fair Price DCF | 44.98 USD |
NUS Dividends
| Dividend Yield 12m | 8.40% |
| Yield on Cost 5y | 2.73% |
| Dividends CAGR 5y | 1.06% |
| Payout Consistency | 100.0% |
NUS Growth Ratios
| Growth 12m | -62.37% |
| Growth Correlation 12m | -72% |
| Growth Correlation 3m | -48% |
| CAGR 5y | -20.11% |
| CAGR/Mean DD 5y | -0.65 |
| Sharpe Ratio 12m | -1.48 |
| Alpha vs SP500 12m | -81.61 |
| Beta vs SP500 5y weekly | 0.90 |
| ValueRay RSI | 73.19 |
| Volatility GJR Garch 1y | 35.40% |
| Price / SMA 50 | -9.92% |
| Price / SMA 200 | -27.57% |
| Current Volume | 404.2k |
| Average Volume 20d | 659.2k |
External Links for NUS Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of July 27, 2024, the stock is trading at USD 10.72 with a total of 404,200 shares traded.
Over the past week, the price has changed by +5.72%, over one month by +0.66%, over three months by -12.52% and over the past year by -61.69%.
According to ValueRays Forecast Model, NUS Nu Skin Enterprises will be worth about 10.1 in July 2025. The stock is currently trading at 10.72. This means that the stock has a potential downside of -5.78%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 12.8 | 19.7 |
| Analysts Target Price | 27.8 | 159 |
| ValueRay Target Price | 10.1 | -5.78 |